Clinical trial
Anti-HIV Immunoglobulin (HIVIG) in Prevention of Maternal-Fetal HIV Transmission…
NCT00000590 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00000590 |
|---|---|
| Title | Anti-HIV Immunoglobulin (HIVIG) in Prevention of Maternal-Fetal HIV Transmission (Pediatric ACTG Protocol 185) |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Collaborators | National Institute of Allergy and Infectious Diseases (NIAID) NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acquired Immunodeficiency Syndrome, Disease Transmission, Vertical, HIV Infections |
| Intervention type | Drug |
| Interventions | immunoglobulins |
| Start date | Sep 1, 1991 |
| Completion | Dec 1, 1996 |
| First posted | Oct 28, 1999 |
| Last update posted | Apr 14, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: